CHARLES SCHWAB INVESTMENT MANAGEMENT INC
Position in ALNY — Alnylam Pharmaceuticals, Inc.
CIK 884546
SAN FRANCISCO, CA
Position in ALNY
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$227,391,137
+$4,597,838 QoQ
Shares Held
755,377
+12.2% QoQ
Ownership
0.565%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#32
of 780 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ALNY Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026CHARLES SCHWAB INVESTMENT MANAGEMENT INC holds $7,346,663,053 across 299 Biotechnology names. ALNY ranks #5 (3.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,041,282 | $1,013,966,007 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
846,306 | $527,705,642 | |
| 3 | RVMD |
Revolution Medicines, Inc.
|
1,917,025 | $359,020,441 | |
| 4 | MRNA |
Moderna, Inc.
|
4,838,884 | $338,867,045 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
This page
|
755,377 | $227,391,137 | |
| 6 | INCY |
Incyte Corp
|
1,692,439 | $191,854,884 | |
| 7 | RPRX |
Royalty Pharma plc
|
3,083,528 | $172,893,414 | |
| 8 | CYTK |
Cytokinetics Inc
|
1,565,781 | $133,388,883 |
All Filings in ALNY
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $227,391,137 | 755,377 | Shares | Other | 2026-08-14 | |
| 2026-03-31 | $222,793,299 | 673,356 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $257,613,178 | 647,839 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $282,159,120 | 618,770 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $186,440,979 | 571,747 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $147,604,272 | 546,642 | Shares | Sole | 2025-09-15 | |
| 2024-12-31 | $120,940,398 | 513,962 | Shares | Sole | 2025-02-06 | |
| 2024-09-30 | $134,035,320 | 487,348 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $114,353,856 | 470,592 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $66,887,842 | 447,560 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $83,895,768 | 438,304 | Shares | Sole | 2024-02-06 | |
| 2023-09-30 | $74,201,358 | 418,980 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $79,042,391 | 416,144 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $81,202,316 | 405,363 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $95,196,886 | 400,576 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $75,833,618 | 378,865 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $54,882,917 | 376,297 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $60,845,609 | 372,623 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $61,550,926 | 362,961 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $66,615,000 | 352,815 | Shares | Sole | 2021-11-16 | |
| 2021-06-30 | $58,201,471 | 343,331 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $47,187,533 | 334,213 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $52,023,871 | 400,276 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $58,324,302 | 400,579 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $93,256,572 | 629,644 | Shares | Sole | 2020-08-20 | |
| 2020-03-31 | $66,487,648 | 610,819 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||